Celldex Therapeutics Inc (CLDX)

03:45 AM

Celldex prices $300M stock at $29 per share to fuel Barzolvolimab launch - msn.com

03:45 AM

Apr 04, 2026

Celldex Therapeutics, Inc. (CLDX) Options Chain - Yahoo! Finance Canada

Apr 04, 2026

Apr 03, 2026

JPMorgan Chase & Co. Sells 49,046 Shares of Celldex Therapeutics, Inc. $CLDX - MarketBeat

Apr 03, 2026

Apr 03, 2026

Celldex Announces Pricing of $300 Million Public Offering of Common Stock - Sahm

Apr 03, 2026

Apr 03, 2026

Celldex Therapeutics stock falls on equity offering - Investing.com

Apr 03, 2026

Apr 02, 2026

Celldex prices $300 million stock offering at $29 per share By Investing.com - Investing.com Australia

Apr 02, 2026

Apr 02, 2026

Celldex Therapeutics offers 10,345,000 shares of common stockSEC filing - MarketScreener

Apr 02, 2026

Apr 02, 2026

Celldex Therapeutics (NASDAQ: CLDX) raises ~$282M net in $29 follow-on offering - Stock Titan

Apr 02, 2026

Apr 02, 2026

Celldex Therapeutics (NASDAQ:CLDX) Sees Unusually-High Trading VolumeHere's Why - MarketBeat

Apr 02, 2026

Apr 02, 2026

Celldex shares plunge after dumping $300 million stock deal - GuruFocus

Apr 02, 2026

Apr 02, 2026

Celldex Therapeutics stock falls on equity offering By Investing.com - Investing.com India

Apr 02, 2026

Apr 02, 2026

Celldex Announces Major Underwritten Public Equity Offering - TipRanks

Apr 02, 2026

Apr 02, 2026

Celldex Therapeutics Inc (TCE2.MU) Stock Price, News, Quote & History - Yahoo! Finance Canada

Apr 02, 2026

Apr 02, 2026

Celldex Therapeutics Prices $29 Share Sale, Expects $282 Million Net From Underwritten Offering - TradingView

Apr 02, 2026

Apr 02, 2026

Celldex (NASDAQ: CLDX) raises $300M in new common stock sale - Stock Titan

Apr 02, 2026

Apr 02, 2026

Is Celldex’s US$300 Million Follow-On To Fund Barzolvolimab Altering The Investment Case For CLDX? - Yahoo Finance

Apr 02, 2026

Apr 02, 2026

Celldex launches public offering of common stock By Investing.com - Investing.com South Africa

Apr 02, 2026

Apr 02, 2026

Celldex Therapeutics Inc (TCE2.DU) Stock Price, News, Quote & History - Yahoo! Finance Canada

Apr 02, 2026

Apr 02, 2026

Celldex Announces $300 Million Public Stock Offering - National Today

Apr 02, 2026

Apr 01, 2026

Celldex Therapeutics, Inc. Announces Pricing of $300 Million Underwritten Public Offering of Common Stock - Quiver Quantitative

Apr 01, 2026

Apr 01, 2026

Celldex prices $300 million stock offering at $29 per share - Investing.com

Apr 01, 2026

Apr 01, 2026

Celldex lines up $300M for drug launch prep and pipeline work - Stock Titan

Apr 01, 2026

Apr 01, 2026

Celldex announces pricing of $300 million public offering of common stock - MarketScreener

Apr 01, 2026

Apr 01, 2026

Celldex announces proposed public offering of common stock - MarketScreener

Apr 01, 2026

Apr 01, 2026

Celldex Announces Proposed Public Offering of Common Stock - bitget.com

Apr 01, 2026

Apr 01, 2026

Celldex Therapeutics (NASDAQ: CLDX) files prospectus supplement for common stock offering - Stock Titan

Apr 01, 2026

Apr 01, 2026

Celldex turns to stock sale to fund drug launch prep and pipeline - Stock Titan

Apr 01, 2026

Apr 01, 2026

CLDX PE Ratio & Valuation, Is CLDX Overvalued - Intellectia AI

Apr 01, 2026

Apr 01, 2026

STOK Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI

Apr 01, 2026

Mar 31, 2026

Celldex Therapeutics (NASDAQ:CLDX) Stock Price Crosses Above 200 Day Moving AverageShould You Sell? - MarketBeat

Mar 31, 2026

Mar 30, 2026

Earnings Report: What makes Celldex Therapeutics Inc stock attractive today2026 Review & Real-Time Volume Trigger Notifications - baoquankhu1.vn

Mar 30, 2026

Mar 29, 2026

Portfolio Recap: Does Celldex Therapeutics Inc stock benefit from AI growth2026 Reactions & Long-Term Safe Investment Plans - baoquankhu1.vn

Mar 29, 2026

Mar 29, 2026

A Look At Celldex Therapeutics (CLDX) Valuation As Shares Show Renewed Momentum - simplywall.st

Mar 29, 2026

Mar 29, 2026

Will Celldex Therapeutics Inc stock hit new highs in YEARQuarterly Growth Report & Expert Curated Trade Ideas - baoquankhu1.vn

Mar 29, 2026

Mar 27, 2026

Celldex Therapeutics presents positive phase 2 data for barzolvolimab in CSU, ColdU, and SD - MarketScreener

Mar 27, 2026

Mar 27, 2026

Celldex reports quality of life gains in urticaria trials - Investing.com

Mar 27, 2026

Mar 27, 2026

Celldex Presents Positive Data from Phase 2 Chronic Spontaneous Urticaria and Phase 2 Cold Urticaria and Symptomatic Dermographism Studies Demonstrating Rapid, Profound and Durable Improvements in Patient Quality of Life at AAD 2026 - Yahoo Finance

Mar 27, 2026

Mar 27, 2026

Celldex reports quality of life gains in urticaria trials By Investing.com - Investing.com Canada

Mar 27, 2026

Mar 26, 2026

Vanguard discloses 0 ownership in Celldex (CLDX) after realignment - stocktitan.net

Mar 26, 2026

Mar 26, 2026

Will Celldex Therapeutics Inc benefit from government policy2026 Risk Factors & High Accuracy Buy Signal Tips - baoquankhu1.vn

Mar 26, 2026

Mar 25, 2026

Mizuho Initiates Coverage of Celldex Therapeutics (CLDX) with Outperform Recommendation - MSN

Mar 25, 2026

Mar 24, 2026

Celldex Therapeutics stock hits 52-week high at 32.8 USD By Investing.com - Investing.com Australia

Mar 24, 2026

Mar 23, 2026

Celldex Therapeutics stock gains after analyst upgrade By Investing.com - Investing.com South Africa

Mar 23, 2026

Mar 23, 2026

Celldex Therapeutics stock gains after analyst upgrade - Investing.com

Mar 23, 2026

Mar 23, 2026

Celldex Therapeutics stock hits 52-week high at 32.8 USD - Investing.com

Mar 23, 2026

Mar 23, 2026

Celldex Therapeutics (NASDAQ:CLDX) Reaches New 1-Year High Following Analyst Upgrade - MarketBeat

Mar 23, 2026